Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

1.1K
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
1.1K
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

5.1K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
5.1K
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

593
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
593
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

1.6K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.6K
Pulse rhythm01:30

Pulse rhythm

1.6K
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
1.6K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

795
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
795

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Utilizing Lead aVR QRS Morphology to Localize Abnormal Substrates in Arrhythmogenic Right Ventricular Cardiomyopathy.

Korean circulation journal·2026
Same author

Mitigating Iatrogenic Air Entrainment During Pulsed Field Ablation: A Comparative Study of a Novel Submerged-Entry Technique Using the VARIPULSE<sup>TM</sup> System.

Circulation reports·2026
Same author

ECG challenge: ST-segment elevation after pulsed-field ablation.

European heart journal. Case reports·2026
Same author

Antagonistic Regulation of the Conifer Age Marker DAL1 by GA and JA Via a TIFY25-DPL1 Module.

Plant, cell & environment·2026
Same author

Prior anticoagulation experience and bleeding risk with the factor XI inhibitor abelacimab in AZALEA-TIMI 71.

Blood·2026
Same author

Renal denervation in experimental autoimmune myocarditis: association with cardiac function and changes in calcium and MAPK/ERK signaling.

Basic research in cardiology·2026

Related Experiment Video

Updated: Apr 23, 2026

Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts
08:43

Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts

Published on: August 26, 2021

2.2K

Pulsed Ultrahigh Frequency Spinal Cord Stimulation for Arrhythmia After Myocardial Infarction.

Chin-Yu Lin1,2, Yung-Tsung Chiu3, Ting-Yung Chang1,2

  • 1Division of Cardiac Electrophysiology, Cardiovascular Center Taipei Veterans General Hospital Taipei Taiwan.

Journal of the American Heart Association
|April 22, 2026
PubMed
Summary

Spinal cord stimulation (SCS) using pulsed ultrahigh frequency (PUF) effectively reduced sympathetic tone and ventricular arrhythmias after myocardial infarction (MI) in pigs. This treatment improved heart function and reduced arrhythmia vulnerability without damaging sympathetic ganglia.

Keywords:
myocardial infarctionpulsed ultrahigh frequencyspinal cord stimulationsympathetic toneventricular arrhythmias

More Related Videos

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.1K
Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
06:57

Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction

Published on: January 31, 2019

16.6K

Related Experiment Videos

Last Updated: Apr 23, 2026

Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts
08:43

Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts

Published on: August 26, 2021

2.2K
Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.1K
Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
06:57

Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction

Published on: January 31, 2019

16.6K

Area of Science:

  • Cardiology
  • Neuroscience
  • Medical Devices

Background:

  • Acute myocardial infarction (MI) elevates sympathetic activity, increasing the risk of fatal ventricular arrhythmias.
  • Investigating interventions to mitigate post-MI sympathetic overactivity and arrhythmia risk is crucial.

Purpose of the Study:

  • To test if spinal cord stimulation (SCS) using pulsed ultrahigh frequency (PUF) can remodel sympathetic activity and reduce ventricular arrhythmias following MI.
  • To evaluate the impact of PUF-SCS on cardiac function and sympathetic ganglia integrity post-MI.

Main Methods:

  • Twenty pigs were divided into control, MI, and MI with PUF-SCS groups.
  • Cardiac function was assessed via echocardiography and Holter monitoring; blood and ganglia analyses were performed.
  • Electrophysiological studies evaluated ventricular fibrillation induction rates post-intervention.

Main Results:

  • MI increased sympathetic tone and arrhythmias; PUF-SCS suppressed these effects.
  • Left ventricular ejection fraction declined post-MI but improved with PUF-SCS.
  • Ventricular fibrillation induction rates decreased significantly in the MI+SCS group compared to the MI group (29% vs. 100%).

Conclusions:

  • Pulsed ultrahigh frequency spinal cord stimulation (PUF-SCS) effectively suppresses sympathetic tone and reduces ventricular arrhythmia burden post-MI.
  • PUF-SCS improved cardiac function and reduced ventricular fibrillation vulnerability without causing sympathetic ganglia damage.
  • The study demonstrates PUF-SCS as a potential therapeutic strategy for managing post-MI complications.